author-photo

Johan Szamosi

AstraZeneca

26

Papers

549

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study

2021 The Lancet Diabetes & Endocrinology
Show All
- Source
- Cite
- Save
Citations (1)
Real-world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders.

2021 Haemophilia
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial.

2020 The Lancet Diabetes & Endocrinology
Show All
- Source
- Cite
- Save
Citations (27)
Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study

2019 BMJ Open
Show All
- Source
- Cite
- Save
Citations (3)
Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania

2015 Journal of Comparative Effectiveness Research
Show All
- Source
- Cite
- Save
Citations (1)
Safety and tolerability of dexmecamylamine (TC-5214) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to antidepressant therapy: results of a long-term study.

2015 Journal of Clinical Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (5)
Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy

2015 World Journal of Biological Psychiatry
Show All
- Source
- Cite
- Save
Citations (27)
Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.

2014 The Journal of Clinical Psychiatry
Show All
- Source
- Cite
- Save
Citations (7)
Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.

2014 International Clinical Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (4)
Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder

2013 Journal of Affective Disorders
Show All
- Source
- Cite
- Save
Citations (6)